Drug Name Ephedraxin

ARICEPT (donepezil HCl) is a prescription medicine to treat mild Alzheimer’s disease (up to 10 mg/day) and moderate to severe Alzheimer’s disease (up to 23 mg/day). Before starting on ARICEPT 23 mg/day, patients should be on ARICEPT 10 mg/day for at least 3 months. The starting dose of ARICEPT is 5 mg/day and can be increased to 10 mg/day after 4-6 weeks. Please take ARICEPT as prescribed by the doctor.
Despite a recent recommendation that hemoglobin A1c (HbA1c) be used as a standard diagnostic test for diabetes, the proposed diagnostic criteria fail to pick up a significant number of cases of diabetes and prediabetes, investigators reported at the 70th Annual Scientific Sessions of the American Diabetes Association.

 

Ampicillin (originally branded as 'Penbritin') also demonstrated activity against Gram-negative organisms such as H. influenzae, coliforms and Proteus spp.
In Europe, it was indicated for use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m2, or patients with a BMI greater than 27 kg/m2 with associated risk factors, such as type 2 diabetes or dyslipidaemia. In the UK, it was available beginning in July 2006. As of 2008, the drug was available in 56 countries.